Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Tiziana Life Sciences Ltd as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q4 2021
- Shares held
- 5.73M
- −89.6K (−1.5%) vs. Q4 2021
- Total value
- $6.02M
- +$385.0K (+6.8%) vs. Q4 2021
- New holders
- 7
- 4 more added
- Sold out
- 7
- 4 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $3.10M |
| Q1 2026 | 32 | $3.67M |
| Q4 2025 | 33 | $3.05M |
| Q3 2025 | 31 | $8.72M |
| Q2 2025 | 30 | $4.04M |
| Q1 2025 | 32 | $3.25M |
| Q4 2024 | 33 | $698.3K |
| Q3 2024 | 30 | $1.78M |
| Q2 2024 | 26 | $1.16M |
| Q1 2024 | 20 | $373.7K |
| Q4 2023 | 21 | $443.4K |
| Q3 2023 | 24 | $521.9K |
| Q2 2023 | 20 | $596.8K |
| Q1 2023 | 18 | $1.15M |
| Q4 2022 | 23 | $3.17M |
| Q3 2022 | 25 | $4.15M |
| Q2 2022 | 24 | $3.97M |
| Q1 2022 | 23 | $6.02M |
| Q4 2021 | 23 | $5.63M |
| Q3 2021 | 23 | $2.04M |
| Q2 2021 | 23 | $13.1M |
| Q1 2021 | 23 | $14.1M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Tiziana Life Sciences Ltd; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tradewinds Capital Management, LLC | 250 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 873 | $1.00K | 0.00% | −1,789−67.2% | Reduced |
| Northwestern Mutual Wealth Management Co | 1,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 1,000 | $1.00K | 0.00% | +1,000 | New |
| IFP Advisors, Inc | 500 | $1.00K | 0.00% | +500 | New |
| Group One Trading, L.P. | 2,330 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,753 | $3.00K | 0.00% | −4,916−64.1% | Reduced |
| Credit Suisse AG | 10,588 | $11.0K | 0.00% | +10,588 | New |
| Citadel Advisors LLC | 13,973 | $15.0K | 0.00% | +13,973 | New |
| Barclays PLC | 17,500 | $18.0K | 0.00% | +17,500 | New |
| Warberg Asset Management LLC | 22,000 | $23.0K | 0.01% | +22,000 | New |
| Bank of America Corp | 26,911 | $28.0K | 0.00% | +19+0.1% | Added |
| Bank of Montreal | 25,000 | $30.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 31,336 | $33.0K | 0.00% | +5,278+20.3% | Added |
| Ausdal Financial Partners, Inc. | 56,900 | $60.0K | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 86,258 | $91.0K | 0.00% | +86,258 | New |
| Morgan Stanley | 94,860 | $100.0K | 0.00% | −19,848−17.3% | Reduced |
| Geode Capital Management, LLC | 185,689 | $194.0K | 0.00% | +43,797+30.9% | Added |
| Citigroup Inc | 250,000 | $263.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 318,788 | $335.0K | 0.00% | +20,799+7.0% | Added |
| HSBC Holdings PLC | 445,554 | $468.0K | 0.00% | −60,000−11.9% | Reduced |
| HighTower Advisors, LLC | 4,131,901 | $4.34M | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −78,267−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −49,439−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −41,028−100.0% | Sold out |
| BlackRock Inc. | 0 | $0 | 0.00% | −30,619−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −25,370−100.0% | Sold out |
| Cypress Capital Management LLC (WY) | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |